Faculty

Institution

Unit

Venue

Michael Plunk

Baylor University

Affiliations

College of Arts & Sciences

Chemistry and Biochemistry

NoneMichael Plunk is currently serving as a Chemistry And Biochemistry faculty at Baylor University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Plunk

Baylor University

You can click a keyword to filter the displayed items

pharmacology drug discovery small molecule inhibitor biomolecular engineering dermatology medicine medicinal chemistry regenerative medicine clinical chemistry enzyme inhibition protein science medicinal research pharmaceutical chemistry transplantation medicine host response renal function structure-activity study soluble guanylyl cyclase gemfibrozil derivatives islet damage allogenic immune responses

Notable Scholarly Works

Notable Federal Grants

Collaborators

P.14A: Small Molecule Inhibitor of Toll-Like Receptor 4, Tak-242, Attenuates Islet Damage Due to Ibmir and Immune Responses. Transplantation (2023)

Jordan MattkeRobert KaneMichael PlunkBashoo Naziruddin

renal functionregenerative medicinesmall molecule inhibitorimmunologymedicinal researchhost responseislet damagemedicinepharmacologytransplantation medicine

Gemfibrozil Derivatives as Activators of Soluble Guanylyl Cyclase – a Structure-Activity Study. European Journal of Medicinal Chemistry (2021)

Kevin M. GaylerJeremy M. QuintanaJordan MattkeMichael A. PlunkJessica H. KostyoJohann W. KarunananthanHarold NguyenMina ShudaLiam D. FerreiraHannah BakerAlexandra L. StinchcombIraida SharinaRobert R. KaneEmil Martin

structure-activity studypharmaceutical chemistrygemfibrozil derivativesprotein sciencesoluble guanylyl cyclasedermatologymedicinal chemistryclinical chemistrypharmacologydrug discoveryenzyme inhibitionbiomolecular engineering

P.161: Small Molecule Inhibitor of Toll-Like Receptor-4, Tak-242, Attenuates Allogenic Immune Responses in Vitro. Transplantation (2021)

Jordan MattkeMichael A. PlunkRobert R. KaneBashoo Naziruddin

immunologyallogenic immune responsespharmacologydrug discoverysmall molecule inhibitor

1
10 / page

Michael Plunk

Baylor University

Affiliations

College of Arts & Sciences

Chemistry and Biochemistry

NoneMichael Plunk is currently serving as a Chemistry And Biochemistry faculty at Baylor University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Plunk

Baylor University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

P.14A: Small Molecule Inhibitor of Toll-Like Receptor 4, Tak-242, Attenuates Islet Damage Due to Ibmir and Immune Responses. Transplantation (2023)

Jordan MattkeRobert KaneMichael PlunkBashoo Naziruddin

renal functionregenerative medicinesmall molecule inhibitorimmunologymedicinal researchhost responseislet damagemedicinepharmacologytransplantation medicine

Gemfibrozil Derivatives as Activators of Soluble Guanylyl Cyclase – a Structure-Activity Study. European Journal of Medicinal Chemistry (2021)

P.161: Small Molecule Inhibitor of Toll-Like Receptor-4, Tak-242, Attenuates Allogenic Immune Responses in Vitro. Transplantation (2021)

Jordan MattkeMichael A. PlunkRobert R. KaneBashoo Naziruddin

immunologyallogenic immune responsespharmacologydrug discoverysmall molecule inhibitor

1
10 / page

Similar Faculty Members

Brian Blagg

Institution

University of Notre Dame

biosynthesis

future medicinal chemistry

David B. Sykes

Institution

Harvard University

hematology

immunology

Catherine Fenselau

Institution

University of Maryland, College Park

applied microbiology

microbial proteomics

Raymond Hohl

Institution

Pennsylvania State University

translational proteomics

clinical proteomics

Daohong Zhou

Institution

University of Florida

cancer letter

anti-cancer agent

Scott L. Diamond

Institution

University of Pennsylvania

gene therapy

systems biology

Francis Castellino

Institution

University of Notre Dame

pharmacology

biochemistry

Mark Quinn

Institution

Montana State University

microbiology

immunology

Barbara Slusher

Institution

Johns Hopkins University

pharmacology

neuroscience

Yon Rojanasakul

Institution

West Virginia University

cancer letter

free radical biology

Similar Faculty Members

Brian Blagg

Institution

University of Notre Dame

biosynthesis

future medicinal chemistry

David B. Sykes

Institution

Harvard University

hematology

immunology

Catherine Fenselau

Institution

University of Maryland, College Park

applied microbiology

microbial proteomics

Raymond Hohl

Institution

Pennsylvania State University

translational proteomics

clinical proteomics

Daohong Zhou

Institution

University of Florida

cancer letter

anti-cancer agent

Scott L. Diamond

Institution

University of Pennsylvania

gene therapy

systems biology

Francis Castellino

Institution

University of Notre Dame

pharmacology

biochemistry

Mark Quinn

Institution

Montana State University

microbiology

immunology

Barbara Slusher

Institution

Johns Hopkins University

pharmacology

neuroscience

Yon Rojanasakul

Institution

West Virginia University

cancer letter

free radical biology